Adaptive Biotechnologies | 144: Notice of proposed sale of securities pursuant to Rule 144
Adaptive Biotechnologies | 10-Q: Q1 2025 Earnings Report
Adaptive Biotechnologies | 8-K: Adaptive Biotechnologies Reports First Quarter 2025 Financial Results
Adaptive Biotechnologies | ARS: Annual Report to Security Holders
Adaptive Biotechnologies | DEFA14A: Others
Adaptive Biotechnologies | DEF 14A: Definitive information statements
Adaptive Biotechnologies | SCHEDULE 13G/A: Others
Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer ROBINS HARLAN S
Adaptive Biotechnologies | 144: Notice of proposed sale of securities pursuant to Rule 144
Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer PISKEL KYLE
Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Director GRIFFIN MICHELLE RENEE
Adaptive Biotechnologies | 144: Notice of proposed sale of securities pursuant to Rule 144
Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Director HERSHBERG ROBERT
Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Director NEUPERT PETER M
Adaptive Biotechnologies | 144: Notice of proposed sale of securities pursuant to Rule 144
Adaptive Biotechnologies | 144: Notice of proposed sale of securities pursuant to Rule 144
Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer LO FRANCIS
Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer BOBULSKY SUSAN
Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer BENZENO SHARON
Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer PISKEL KYLE